Cargando…

In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis

BACKGROUND: Strongyloidiasis is a parasitic disease widely present in tropical and subtropical areas. Strongyloides stercoralis represents the main species that infects human beings. Ivermectin is the current drug of choice; however, issues related with treatment failure in patients with diabetes or...

Descripción completa

Detalles Bibliográficos
Autores principales: Legarda-Ceballos, Ana L., López-Abán, Julio, del Olmo, Esther, Escarcena, Ricardo, Bustos, Luis A., Rojas-Caraballo, Jose, Vicente, Belén, Fernández-Soto, Pedro, San Feliciano, Arturo, Muro, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924291/
https://www.ncbi.nlm.nih.gov/pubmed/27353595
http://dx.doi.org/10.1186/s13071-016-1648-5
_version_ 1782439844312514560
author Legarda-Ceballos, Ana L.
López-Abán, Julio
del Olmo, Esther
Escarcena, Ricardo
Bustos, Luis A.
Rojas-Caraballo, Jose
Vicente, Belén
Fernández-Soto, Pedro
San Feliciano, Arturo
Muro, Antonio
author_facet Legarda-Ceballos, Ana L.
López-Abán, Julio
del Olmo, Esther
Escarcena, Ricardo
Bustos, Luis A.
Rojas-Caraballo, Jose
Vicente, Belén
Fernández-Soto, Pedro
San Feliciano, Arturo
Muro, Antonio
author_sort Legarda-Ceballos, Ana L.
collection PubMed
description BACKGROUND: Strongyloidiasis is a parasitic disease widely present in tropical and subtropical areas. Strongyloides stercoralis represents the main species that infects human beings. Ivermectin is the current drug of choice; however, issues related with treatment failure in patients with diabetes or infected with T-lymphotropic virus-1 make the identification of new molecules for alternative treatment a priority. In the present study, the activity of sphingosine-related aminoalcohol and diamine were evaluated against Strongyloides venezuelensis third-stage larva (L3) cultures and experimental infections in mice. METHODS: The efficacy of each compound against L3 was assessed using both XTT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) assay and microscopic observation with concentrations ranging from 1 to 350 μM. Cytotoxicity was evaluated using J774.2 macrophage cell line and XTT assay. Lethal concentration 50 (LC(50)), selectivity index (SI) and structure-activity relationships were established. The activity compounds 4 (2-(ethylamino) hexadecan-1-ol), 6 (2-(butylamino) hexadecan-1-ol), 17 (tert-butyl N-(1-aminododecan-2-yl) carbamate) and 18 (tert-butyl N-(1-aminohexadecan-2-yl) carbamate) were further assessed against experimental S. venezuelensis infections in CD1 mice measuring reductions in the numbers of parthenogenetic females and egg passed in faeces. Mice were infected with 3,000 L3 and treated with 20 mg/kg/day for five days. RESULTS: In the screening study of 15 aminoalcohols [lauryl (n = 9); palmityl (n = 13); stearyl (n = 15) and alcohol derivatives], the presence of a palmitol chain was associated with the highest efficacy against L3 (LC(50) 31.9–39.1 μM). Alkylation of the 2-amino group with medium size fragments as ethyl or n-butyl showed the best larvicidal activity. The dialkylation did not improve efficacy. Aminoalcohols 4 and 6 showed the highest SI (1.5 and 1.6, respectively). With respect to diamine derivative compounds, a chain size of sixteen carbon atoms (palmitoyl chain, n = 13), and the alkylation of the 2-amino group with medium-sized fragments, were associated with the highest lethal activities. The presence of carbamoyl group in diamines 17 and 18 yielded high SI (1.7 and 1.4, respectively). Infected mice treated with aminoalcohol 6 showed reduction in parthenogenetic females (59 %) and eggs in faeces (51 %). CONCLUSIONS: These results support the potentiality of aminoalcohol and diamine sphingosine-related compounds as suitable prototypes for developing new promising drugs against strongyloidiasis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13071-016-1648-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4924291
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49242912016-06-29 In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis Legarda-Ceballos, Ana L. López-Abán, Julio del Olmo, Esther Escarcena, Ricardo Bustos, Luis A. Rojas-Caraballo, Jose Vicente, Belén Fernández-Soto, Pedro San Feliciano, Arturo Muro, Antonio Parasit Vectors Research BACKGROUND: Strongyloidiasis is a parasitic disease widely present in tropical and subtropical areas. Strongyloides stercoralis represents the main species that infects human beings. Ivermectin is the current drug of choice; however, issues related with treatment failure in patients with diabetes or infected with T-lymphotropic virus-1 make the identification of new molecules for alternative treatment a priority. In the present study, the activity of sphingosine-related aminoalcohol and diamine were evaluated against Strongyloides venezuelensis third-stage larva (L3) cultures and experimental infections in mice. METHODS: The efficacy of each compound against L3 was assessed using both XTT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) assay and microscopic observation with concentrations ranging from 1 to 350 μM. Cytotoxicity was evaluated using J774.2 macrophage cell line and XTT assay. Lethal concentration 50 (LC(50)), selectivity index (SI) and structure-activity relationships were established. The activity compounds 4 (2-(ethylamino) hexadecan-1-ol), 6 (2-(butylamino) hexadecan-1-ol), 17 (tert-butyl N-(1-aminododecan-2-yl) carbamate) and 18 (tert-butyl N-(1-aminohexadecan-2-yl) carbamate) were further assessed against experimental S. venezuelensis infections in CD1 mice measuring reductions in the numbers of parthenogenetic females and egg passed in faeces. Mice were infected with 3,000 L3 and treated with 20 mg/kg/day for five days. RESULTS: In the screening study of 15 aminoalcohols [lauryl (n = 9); palmityl (n = 13); stearyl (n = 15) and alcohol derivatives], the presence of a palmitol chain was associated with the highest efficacy against L3 (LC(50) 31.9–39.1 μM). Alkylation of the 2-amino group with medium size fragments as ethyl or n-butyl showed the best larvicidal activity. The dialkylation did not improve efficacy. Aminoalcohols 4 and 6 showed the highest SI (1.5 and 1.6, respectively). With respect to diamine derivative compounds, a chain size of sixteen carbon atoms (palmitoyl chain, n = 13), and the alkylation of the 2-amino group with medium-sized fragments, were associated with the highest lethal activities. The presence of carbamoyl group in diamines 17 and 18 yielded high SI (1.7 and 1.4, respectively). Infected mice treated with aminoalcohol 6 showed reduction in parthenogenetic females (59 %) and eggs in faeces (51 %). CONCLUSIONS: These results support the potentiality of aminoalcohol and diamine sphingosine-related compounds as suitable prototypes for developing new promising drugs against strongyloidiasis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13071-016-1648-5) contains supplementary material, which is available to authorized users. BioMed Central 2016-06-28 /pmc/articles/PMC4924291/ /pubmed/27353595 http://dx.doi.org/10.1186/s13071-016-1648-5 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Legarda-Ceballos, Ana L.
López-Abán, Julio
del Olmo, Esther
Escarcena, Ricardo
Bustos, Luis A.
Rojas-Caraballo, Jose
Vicente, Belén
Fernández-Soto, Pedro
San Feliciano, Arturo
Muro, Antonio
In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis
title In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis
title_full In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis
title_fullStr In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis
title_full_unstemmed In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis
title_short In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis
title_sort in vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against strongyloides venezuelensis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924291/
https://www.ncbi.nlm.nih.gov/pubmed/27353595
http://dx.doi.org/10.1186/s13071-016-1648-5
work_keys_str_mv AT legardaceballosanal invitroandinvivoevaluationof2aminoalkanoland12alkanediaminederivativesagainststrongyloidesvenezuelensis
AT lopezabanjulio invitroandinvivoevaluationof2aminoalkanoland12alkanediaminederivativesagainststrongyloidesvenezuelensis
AT delolmoesther invitroandinvivoevaluationof2aminoalkanoland12alkanediaminederivativesagainststrongyloidesvenezuelensis
AT escarcenaricardo invitroandinvivoevaluationof2aminoalkanoland12alkanediaminederivativesagainststrongyloidesvenezuelensis
AT bustosluisa invitroandinvivoevaluationof2aminoalkanoland12alkanediaminederivativesagainststrongyloidesvenezuelensis
AT rojascaraballojose invitroandinvivoevaluationof2aminoalkanoland12alkanediaminederivativesagainststrongyloidesvenezuelensis
AT vicentebelen invitroandinvivoevaluationof2aminoalkanoland12alkanediaminederivativesagainststrongyloidesvenezuelensis
AT fernandezsotopedro invitroandinvivoevaluationof2aminoalkanoland12alkanediaminederivativesagainststrongyloidesvenezuelensis
AT sanfelicianoarturo invitroandinvivoevaluationof2aminoalkanoland12alkanediaminederivativesagainststrongyloidesvenezuelensis
AT muroantonio invitroandinvivoevaluationof2aminoalkanoland12alkanediaminederivativesagainststrongyloidesvenezuelensis